Literature DB >> 32947011

Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway.

Yujia Li1, Chun Jin1, Min Shen1, Zhenyi Wang1, Shanzhong Tan2, Anping Chen3, Shijun Wang4, Jiangjuan Shao1, Feng Zhang1, Zili Zhang5, Shizhong Zheng6.   

Abstract

BACKGROUND: Currently, the existing treatments have not cured the liver fibrosis thoroughly. Ferroptosis is a newly discovered way of cell death, which is closely related to many diseases. Previous studies have shown that ferroptosis plays an important role in the occurrence and development of liver fibrosis, but the further mechanism remains to be discovered.
METHODS: LX-2 cells were used as the research object, fibrosis activation index was detected by Western blot, PCR and Immunofluorescence, ferroptosis was detected by kits, the binding and interaction between IRP2 (iron regulatory protein 2) and STUB1 (STIP1 homology and U-box containing protein 1) were detected by Immunoprecipitation and ubiquitin test, and IRP2 knockdown mice were constructed by interfering plasmid to verify the results of in vitro experiment. RESULT: Our research showed that ART (artemether) had a good anti-fibrosis effect in vivo and in vitro, and ferroptosis played an important role in this process. Further studies have found that ART could lead to the accumulation of IRP 2 a in hepatic stellate cell by inhibiting the ubiquitination of it, thus inducing the increase of iron in HSC (hepatic stellate cell), which could product a large number of ROS (reactive oxide species), resulting the occurrence of ferroptosis in cells. Our findings provided an experimental basis for ART to become a drug for the treatment of liver fibrosis.
CONCLUSION: Our results show that IRP2-Iron-ROS axis is necessary for ART to induce ferroptosis in HSC and play an anti-fibrotic effect.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ART; Ferroptosis; IRP2; Iron; Liver fibrosis; ROS

Mesh:

Substances:

Year:  2020        PMID: 32947011     DOI: 10.1016/j.freeradbiomed.2020.09.008

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

1.  miR-29a-3p in Exosomes from Heme Oxygenase-1 Modified Bone Marrow Mesenchymal Stem Cells Alleviates Steatotic Liver Ischemia-Reperfusion Injury in Rats by Suppressing Ferroptosis via Iron Responsive Element Binding Protein 2.

Authors:  Xiang Li; Longlong Wu; Xuan Tian; Weiping Zheng; Mengshu Yuan; Xiaorong Tian; Huaiwen Zuo; Hongli Song; Zhongyang Shen
Journal:  Oxid Med Cell Longev       Date:  2022-06-09       Impact factor: 7.310

2.  Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1.

Authors:  Piao Luo; Dandan Liu; Qian Zhang; Fan Yang; Yin-Kwan Wong; Fei Xia; Junzhe Zhang; Jiayun Chen; Ya Tian; Chuanbin Yang; Lingyun Dai; Han-Ming Shen; Jigang Wang
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

Review 3.  Role of Ferroptosis in Fibrotic Diseases.

Authors:  Jian Zhou; Yuan Tan; Rurong Wang; Xuehan Li
Journal:  J Inflamm Res       Date:  2022-06-27

Review 4.  Therapeutic Implications of Ferroptosis in Renal Fibrosis.

Authors:  Yao Zhang; Yanhua Mou; Jianjian Zhang; Chuanjian Suo; Hai Zhou; Min Gu; Zengjun Wang; Ruoyun Tan
Journal:  Front Mol Biosci       Date:  2022-05-17

Review 5.  The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases.

Authors:  Yijing Ren; Siyue Li; Zixuan Song; Qiuping Luo; Yingying Zhang; Hao Wang
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

6.  FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis.

Authors:  Wanye Hu; Chaoting Zhou; Qiangan Jing; Yancun Li; Jing Yang; Chen Yang; Luyang Wang; Jiayu Hu; Huanjuan Li; Hairui Wang; Chen Yuan; Yi Zhou; Xueying Ren; Xiangmin Tong; Jing Du; Ying Wang
Journal:  Cancer Cell Int       Date:  2021-12-29       Impact factor: 5.722

Review 7.  The Emerging Role of Ferroptosis in Liver Diseases.

Authors:  Si Chen; Jun-Yao Zhu; Xin Zang; Yong-Zhen Zhai
Journal:  Front Cell Dev Biol       Date:  2021-12-14

8.  Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis.

Authors:  Jiazhi Yi; Shuyun Wu; Siwei Tan; Yunfei Qin; Xing Wang; Jie Jiang; Huiling Liu; Bin Wu
Journal:  Cell Death Discov       Date:  2021-12-04

Review 9.  Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives.

Authors:  Yang Nan; HongChan Su; XiaoMei Lian; Juan Wu; SuJie Liu; PingPing Chen; ShuMin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-28       Impact factor: 2.650

Review 10.  Ferroptosis and Liver Fibrosis.

Authors:  Qi Pan; Yi Luo; Qiang Xia; Kang He
Journal:  Int J Med Sci       Date:  2021-07-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.